Mesonephric-like adenocarcinoma of the uterine corpus with focal sarcomatous differentiation: A case report

Case report OA: gold CC-BY-4.0
⚙ AI-generated summary by qwen3.7-flash, 2026-09-08 ⓘ

This case report describes a patient initially diagnosed with cervical carcinoma who was subsequently found to have mesonephric-like adenocarcinoma of the uterine corpus with focal sarcomatous differentiation following surgical resection.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-07 · read from full text ⓘ

This case report describes a 65-year-old postmenopausal woman diagnosed with primary mesonephric-like adenocarcinoma of the uterine corpus, characterized by focal sarcomatous differentiation and initial misdiagnosis as small cell neuroendocrine carcinoma. The patient presented with asymptomatic lung metastases and underwent chemotherapy followed by modified radical hysterectomy, revealing that the tumor originated in the uterine corpus rather than the cervix despite its extension. Although the disease initially responded to treatment, the patient later developed cerebral metastases, highlighting the aggressive nature and diagnostic challenges associated with this rare malignancy. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Mesonephric-like adenocarcinoma of the uterine corpus was first reported in 2016, and added as a new item to the 5th edition of the WHO classification in 2020. It accounts for approximately 1% of patients with uterine corpus cancer, being rare. The histology of this carcinoma varies, making pathological diagnosis difficult. A diagnosis is made at an advanced stage in comparison with other histological types of uterine corpus cancer, and the prognosis is reportedly poor with high-level malignancy. In addition, there are few case reports of mesonephric-like adenocarcinoma of the uterine corpus with sarcoma. In this study, we report a patient in whom preoperative chemotherapy was performed under a diagnosis of cervical carcinoma, but the resected specimen led to a diagnosis of sarcomatous component-mixed mesonephric-like adenocarcinoma of the uterine corpus after surgery.
Full text 15,737 characters · extracted from pmc-nxml · 1 sections · click to expand

Section 1

We encountered an extremely rare patient with primary MLA of the uterine corpus accompanied by the sarcomatous component. The malignancy level of MLA is higher than that of other histological types of uterine corpus cancer, and the prognosis is poor. However, neither treatment nor follow-up strategies have been established. In the future, a larger number of patients should be accumulated for further research.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:47:46.408626+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC